Bronchodilator response to formoterol after regular tiotropium or to tiotropium after regular formoterol in COPD patients

Respiratory Medicine

Volumn 99, Issue 5, 2005, Pages 524-528

  Cazzola, Mario ^a,c   Noschese, Paolo ^a   Salzillo, Antonello ^a   De Giglio, Carlo ^a   D'Amato, Gennaro ^a   Matera, Maria Gabriella ^b  

^a CARDARELLI HOSPITAL   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c NONE   (Italy)

Author keywords

COPD; Formoterol; Sequential therapy; Tiotropium

Indexed keywords

BRONCHODILATING AGENT; FLUORINATED HYDROCARBON; FORMOTEROL; TIOTROPIUM BROMIDE;

AREA UNDER THE CURVE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG DELIVERY SYSTEM; DRUG POTENTIATION; DRUG RESPONSE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATION; INHALER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ANALYSIS OF VARIANCE; AREA UNDER CURVE; BRONCHODILATOR AGENTS; CHOLINERGIC ANTAGONISTS; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ETHANOLAMINES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SCOPOLAMINE DERIVATIVES;

EID: 16344372165     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2004.10.004     Document Type: Article

References (13)

1. M. Cazzola D. Spina M.G. Matera The use of bronchodilators in stable chronic obstructive pulmonary disease Pulm Pharmacol Ther 10 1997 129-144
2. P.M. Dorinsky C. Reisner G.T. Ferguson S.S. Menjoge C.W. Serby T.J. Witek Jr The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPD Chest 115 1999 966-971
3. M. Cazzola M.G. Matera E. Di Perna C. Califano M. D'Amato G. Mazzarella Influence of higher than conventional doses of oxitropium bromide on formoterol-induced bronchodilation in COPD Respir Med 93 1999 909-911
4. M. Cazzola F. Di Marco P. Santus B. Boveri M. Verga M.G. Matera S. Centanni The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD Pulm Pharmacol Ther 17 2004 35-39
5. M. Cazzola S. Centenni P. Santus M. Verga M. Mondoni F. Di Marco M.G. Matera The functional impact of adding salmeterol and tiotropium in patients with stable COPD Respir Med 2004 in press
6. S.I. Rennard Combination bronchodilator therapy in COPD Chest 107 Suppl 1995 171S-175S
7. American Thoracic Society Standardization of spirometry, 1994 Update Am J Respir Crit Care Med 152 1995 1107-1136
8. M. Cazzola F. Di Perna C. Califano A. Vinciguerra M. D'Amato Incremental benefit of adding oxitropium bromide to formoterol in patients with stable COPD Pulm Pharmacol Ther 12 1999 267-271
9. J.P. Karpel Bronchodilator responses to anticholinergic and β-adrenergic agents in acute and stable COPD Chest 99 1991 871-876
10. D.M. Newnham D.P. Dhillon J.H. Winter C.M. Jackson R.A. Clark B.J. Lipworth Bronchodilator reversibility to low and high doses of terbutaline and ipratropium bromide in patients with chronic obstructive pulmonary disease Thorax 48 1993 1151-1155
11. 2 adrenergic agonist and an anticholinergic agent given by sequential inhalation in patients with severe chronic obstructive pulmonary disease Isr J Med Sci 27 1991 307-310
12. N.J. Gross M.S. Skorodin Role of the parasympathetic system in airway obstruction due to emphysema N Engl J Med 311 1984 421-425
13. N.J. Douglas I. Davidson M.F. Sudlow D.C. Flenley Bronchodilatation and the site of airway resistance in severe chronic bronchitis Thorax 34 1979 51-56